Login to Your Account

Chroma, Cell Therapeutics Pact Paves the Way for Tosedostat

By Nuala Moran

Tuesday, March 15, 2011
LONDON – Chroma Therapeutics has forged a collaboration with Cell Therapeutics Inc., in which the two companies will co-develop Chroma's tosedostat, an orally available cancer treatment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription